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Using two independent analyses, it is demonstrated that natural (e.g., estradiol) and some
xenoestrogens (e.g., methoxychlor metabolite) are characterized by a lipophilic region that is
absent in nonestrogens as well as in phytoestrogens. It is suggested that this lipophilic region
affects binding to specific receptors and may, in fact, differentiate harmful from beneficial
estrogens. Environ Health Perspect 105(Suppl 3):665-668 (1997)
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Introduction
Recently, we identified a 6A 2-dimen-
sional distance (2D) descriptor associated
with the carcinogenicity in mice ofestro-
gens (e.g., diethylstilbestrol and 170-estra-
diol) (1). This descriptor (biophore) was
originally recognized during structure-
activity relationship (SAR) studies of
diethylstilbestrol (2) and tamoxifen and
toremifene (3), using the SAR expert
systems computer automated structure
evaluator (CASE) and multiple case
(MULTICASE). This biophore was
derived from the CASE/MULTICASE
learning set ofmurine carcinogens (4-8).
Based on its presence in carcinogenic
estrogens, we suggested that the 2D bio-
phore represented a ligand binding site on
an estrogen receptor (1). This hypothesis
was supported by the realization that the
biophore was derived from estrogens in
the carcinogenicity database and the fact
that CASE/MULTICASE had been
programed to recognize 2D biophores that
possess lipophilic centers as well as moi-
eties capable ofhydrogen bonding. These
characteristics are associated with ligands
that bind to cellular receptors. Hence this
finding is consistent with an estrogen pos-
sessing a hydrogen-bonding moiety at one
end and a lipophilic moiety on the other.
In fact, CASE/MULTICASE identified it
as a lipophilic, anchored, p-substituted
phenol moiety (Figure 1). This 2D
descriptor is absent from the vast majority
ofnonestrogens.
Using CASE/MULTICASE, we identi-
fied a number of chemicals, including
many estrogens and xenoestrogens, that
possess this 2D moiety (Table 1), as well as
a number ofestrogens that lack it. However,
some ofthe estrogens devoid ofthis moiety
acquire it following metabolic activation,
e.g., tamoxifen metabolism to 4-hydroxy-
tamoxifen; the latter is the metabolite
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thought to be responsible for the estro-
genicity ofthe parent molecule (9). On the
other hand, phytoestrogens, as a group,
lack this descriptor (Table 1). These find-
ings suggest that the presence of the 2D
descriptor could be used to classify estro-
gens with respect to possible risk to
humans and to the ecological biota, or
even to distinguish between harmful
(xenoestrogens) and potentially beneficial
estrogens (e.g., phytoestrogens).
While we do not expect this 2D
biophore to provide a unifying principle
that accounts for the action ofestrogens, it
might provide further insight into their
mechanism ofaction. In the present study
we expand the definition of the 2D
biophore, especially with respect to its
putative lipophilicity.
Methods
The CASE/MULTICASE methodologies
have been described on a number ofocca-
sions (10,11). The 6A moiety (above)
identified by CASE/MULTICASE involves
phenol substitution at the p-position with
a carbon atom. The specific lipophilicity
of the p-substituent is specified by
CASE/MULTICASE to include carbon
atoms that are four bonds away from
heteroatoms. By this criteria 17,-estradiol
was identified as possessing the appro-
priate lipophilic moiety while the car-
bon para to the phenol in genistein was
found to lack it. To clarify the lipophil-
icity of the 2D biophore, we analyzed a
group of molecules with Molecular
Modeling Pro (MMP) (12) for the pres-
ence, location, and characteristics of their
lipophilic regions.
Briefly, MMP assigns values for the
lipophilicity of each atom of a molecule
using the procedure of Hansch and Leo
(13). For example, a value of 0.23 is
assigned to hydrogens, 0.13 to carbons with
one hydrogen, 0.22 to carbons with two or
more hydrogens, -1.14 to hydroxyl groups,
and -2.24 to keto oxygens. Each atom is
also modified by its neighbors. The value of
atoms a are multiplied by 0.5, i by 0.25, y
by 0.125, and 6 by 0.0625. These values
are totaled and added to the value of the
atom of interest. After all calculations are
completed, atoms with negative values are
designated "hydrophilic" and those with
positive values as "lipophilic." MMP then
colors each atom to denote its degree of
lipophilicity or hydrophilicity (Figure 1).
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Figure 1. Estrogenic chemicals painted according to lipophilicity. The 6A 2D biophore is illustrated in 4-methylphenol. All chemicals shown possess the physical distance
requirements ofthe biophore. *Methoxychlor metabolite =2,2-bis(p-hydroxyphenyl)-1,1,1-trichloroethane; 2-chlorobiphenyl metabolite =2-chloro-4-hydroxybiphenyl.
Results and Discussion
Not all estrogens contain the 2D biophore
(above) (Table 1). The simplest molecule
that contains this biophore, 4-methylphenol
(Figure 1), can illustrate the biophore. The
1-position of4-methylphenol contains the
hydroxyl group that is both hydrophilic
and capable ofhydrogen bonding. The 4-
position is occupied by a benzylic methyl
group that is in a lipophilic environment.
In general, the benzylic carbon can be
methyl, methylene, methine, or quater-
nary. Between the p-hydroxyl group and
the lipophilic moiety is a conjugated six-
membered ring system that may be substi-
tuted at some positions (1). The structure
of4-methylphenol can be superimposed on
other molecules for easy identification of
the 2D biophore.
The major aim ofthis investigation was
to visualize and confirm, using MMP, that
in fact the MULTICASE biophore is
indeed anchored in a lipophilic region.
This is readily demonstrated (Figure 1). All
the chemicals shown in Figure 1 possess
the physical distance requirements of the
biophore (i.e., 6A from phenol to benzylic
carbon); however, the chemicals that lack
the biophore have a benzylic carbon atom
located in a region that is either hydrophilic
or only somewhat lipophilic. For example,
diethylstilbestrol (DES) and 17p-estradiol,
which possess the 2D biophore, have a
large lipophilic region that encompasses
the p-substituted carbon. On the other
hand, dietary estrogens such as coumestrol
and genistein, which lack the biophore,
have the corresponding carbon embedded
in a region intermediate between lipophilic
and hydrophilic (Figure 1).
For chemicals to have a lipophilic area
at the alkyl end of the 2D biophore, het-
eroatoms (e.g., oxygen atoms) must be suf-
ficiently distant from the p-carbon. Thus
chemicals such as the dietary estrogens
with their intra- and extracyclic oxygens
produce an environment that is not
very lipophilic and hence the biophore
is absent.
The 2D biophore was originally
identified from a carcinogenicity database
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Table 1. Distribution ofthe 2D biophore among selected estrogenic and antiestrogenic chemicals.
Chemical Type 2D
Phytoestrogens
2',4,4',6'-Tetrahydroxydihydrochalcone (phloretin) Phytoestrogen -
5,7-Dihydroxyflavone (chrysin) Phytoestrogen -
3,5,7-Rihydroxyflavone (galangin) Phytoestrogen -
4',5,7-Trihydroxyflavone (apigenin) Phytoestrogen -
3,3',4',7-Tetrahydroxyflavone (fisetin) Phytoestrogen -
3',4',5,7-Tetrahydroxyflavone (luteolin) Phytoestrogen -
3,4',5,7-Tetrahydroxyflavone (kaempferol) Phytoestrogen -
3,5,7-Trihydroxy-4'-methoxyflavone (kaempferide) Phytoestrogen -
3,3',4',5,7-Pentahydroxyflavone (quercetin) Phytoestrogen -
2',3,4',5,7-Pentahydroxyflavone (morin) Phytoestrogen -
4',5,7-Trihydroxyflavanone (naringenin) Phytoestrogen -
3',5,7-Trihydroxy-4'-methoxyflavanone (hesperetin) Phytoestrogen -
3,3',4',5,7-Pentahydroxyflavanone (taxifolin) Phytoestrogen -
4',7-Dihydroxyisoflavone (diadzein) Phytoestrogen -
4',5,7-Trihydroxyisoflavone (genistein) Phytoestrogen -
5,7-Dihydroxy-4'-methoxyisoflavone (biochanin A) Phytoestrogen -
Coumestrol Phytoestrogen -
4,4'-Dihydroxystilbene Phytoestrogen +
a-Sitosterol Phytoestrogen -
Zearalenone Phytoestrogen -
Tetrahydrocannabinol Phytoestrogen -
Xenoestrogens and therapeutics
o,p'-DDE Xenoestrogen -
Chlordecone Xenoestrogen -
4-Nonylphenol Xenoestrogen +
4-tert-Butylphenol Xenoestrogen +
DES Estrogen +
Indenestrol A DES metabolite +
4',4"-Diethylstilbestrol quinone DES metabolite
TMX Antiestrogen
4-Hydroxytamoxifen acid TMX metabolite +
TRM Antiestrogen
4-Hydroxydeaminohydroxytoremifene TRM metabolite +
ICI 164,384 Antiestrogen +
ICI 182,780 Antiestrogen +
LY 117018 Antiestrogen
MER 25 Antiestrogen
17fi-Estradiol Estrogen +
17a-Ethinyl estradiol Estrogen +
Benzestrol Estrogen +
Dienestrol Estrogen +
Estriol Estrogen +
Estrone Estrogen +
Hexestrol Estrogen +
Megestrol Estrogen
Norgestrol Estrogen
Norlestrin Estrogen +
Phenol red pH indicator
Bis(4-hydroxyphenyl)(2-(phenoxy-sulfonyl)phenyl)methane* Xenoestrogen +
Abbreviations: TMX, tamoxifen; TRM, toremifene. *This chemical has been identified as the estrogenic impurity of
commercial phenol red preparations (14).
(above). The dichotomy between estrogens
that display a lipophilic center and those
that do not may in fact separate harmful
(e.g., carcinogenic) from beneficial (or at
least benign) estrogens. Thus carcinogenic
estrogens or their metabolites (e.g., DES,
tamoxifen, and 17P-estradiol) possess the
2D biophore and have independently been
shown, using MMP, to be lipophilic. In
addition, xenoestrogens such as the
metabolites ofmethoxychlor, polychlori-
nated biphenyls, and polycyclic aromatic
hydrocarbons also possess this biophore
and in fact have a lipophilic region at
which to anchor the biophore (Figure 1).
On the other hand, dietary phytoestrogens
(e.g., genistein, coumestrol, etc.), some of
which are thought to be cancer chemopre-
ventive agents, lack this biophore and have
been shown herein to lack the lipophilic
region (Figure 1).
The 2D biophore and associated
lipophilic region appear to have biological
significance and are not random occur-
rences among estrogenic chemicals. Indeed,
the lipophilic region associated with the
2D biophore may modulate the binding
affinities for these estrogens at different
ligand-binding sites (e.g., estrogen receptor
or estrogen-metabolizing enzymes).
The current report confirms that the
2D biophore describes a lipophilic center.
This biophore is able to distinguish
between some beneficial (e.g., genistein
and other phytoestrogens) and some harm-
ful (e.g., DES) estrogens. The ability of
this biophore to differentiate estrogens sug-
gests that estrogens elicit their responses
through various mechanisms. Moreover,
this dichotomy suggests that some estro-
genic responses may be distinguishable
from carcinogenic responses resulting from
the action of the estrogens, since not all
estrogens are carcinogens. The lipophilic
moiety described herein may be involved
in this dichotomy.
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